Clinical Trial Update: Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating docetaxel plus capecitabine for metastatic stomach or gastroesophageal junction cancer has completed. The trial was sponsored by the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED